Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Finch Therapeutics Group Inc

FNCH
Current price
3.84 USD -0.09 USD (-2.29%)
Last closed 4.18 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 209 862 USD
Yield for 12 month +320.04 %
Week
Month
Year
FNCH
21.11.2021 - 28.11.2021

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524, FIN-525, and other microbiome product candidates for inflammatory bowel disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Address: 200 Inner Belt Road, Somerville, MA, United States, 02143

Analytics

WallStreet Target Price

90 USD

P/E ratio

Dividend Yield

Current Year

+861 000 USD

Last Year

+18 532 000 USD

Current Quarter

Last Quarter

Current Year

+861 000 USD

Last Year

+18 532 000 USD

Current Quarter

Last Quarter

Key Figures FNCH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -53 946 000 USD
Operating Margin TTM -49417.39 %
PE Ratio
Return On Assets TTM -28.71 %
PEG Ratio
Return On Equity TTM -134.61 %
Wall Street Target Price 90 USD
Revenue TTM 115 000 USD
Book Value 16.08 USD
Revenue Per Share TTM 0.072 USD
Dividend Share
Quarterly Revenue Growth YOY -69.8 %
Dividend Yield
Gross Profit TTM -57 032 000 USD
Earnings Share -61.48 USD
Diluted Eps TTM -61.48 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics FNCH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FNCH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 12.06.2023
Dividend Date

Stock Valuation FNCH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 80.025
Price Sales TTM 62.6945
Enterprise Value EBITDA -0.1706
Price Book MRQ 0.2793

Financials FNCH

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators FNCH

For 52 weeks

3.35 USD 30 USD
50 Day MA 4.27 USD
Shares Short Prior Month 20 447
200 Day MA 8.16 USD
Short Ratio 4.26
Shares Short 19 653
Short Percent 2.17 %